Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs directed at expanding the horizons of cytokine-based immunotherapy, especially for cancers where treatment choices remain limited. Use the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline https://financefeeds.com/bitwise-pushes-for-a-doge-etf-but-experts-predict-xyzverse-xyz-will-outperform-in-2025/